Finance

Lists
Why is 300006 up 3,42%?
Dive Deeper
300006:SHE
Chongqing Lummy Pharmaceutical Co Ltd
CN¥8,17
+3,42%
(+0,27) 1D
15 Okt., 10:51:28 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300006...
Open
CN¥8,68
High
CN¥8,84
Low
CN¥7,81
Mkt. cap
6,95 mjd
Avg. vol.
45,88 m
Volume
220,14 m
52-wk high
CN¥8,84
52-wk low
CN¥4,28
EPS
-CN¥0,12
Shares outstanding
1,06 mjd
No. of employees
973
Open
CN¥8,68
High
CN¥8,84
Low
CN¥7,81
Mkt. cap
6,95 mjd
Avg. vol.
45,88 m
Volume
220,14 m
52-wk high
CN¥8,84
52-wk low
CN¥4,28
EPS
-CN¥0,12
Shares outstanding
1,06 mjd
No. of employees
973
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
25 minute gelede
FILE PHOTO: SK Hynix at the Nasdaq market in New York
Yardeni QuickTakes
Yardeni QuickTakes
·
1 minuut gelede
Continue To Proceed With Caution
The Globe and Mail
The Globe and Mail
·
42 minute gelede
U.S. Analyst Updates: October 14th, 2026
About Chongqing Lummy Pharmaceutical Co Ltd
CEO-
Employees973
Founded06 Sep. 1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
203,87 m
194,62 m
182,21 m
168,23 m
Cost of goods sold
88,47 m
95,76 m
81,98 m
88,59 m
Cost of revenue
88,47 m
95,76 m
81,98 m
88,59 m
Research and development expenses
16,87 m
23,31 m
9,55 m
8,37 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
115,07 m
113,44 m
95,53 m
74,44 m
Operating expense
131,03 m
141,33 m
105,67 m
81,94 m
Total operating expenses
219,50 m
237,10 m
187,65 m
170,53 m
Operating income
-15,63 m
-42,47 m
-5,44 m
-2,30 m
Other non operating income
-14,85 k
62,06 k
-751,55 k
-699,11 k
EBT including unusual items
-18,59 m
-99,22 m
-17,11 m
-5,30 m
EBT excluding unusual items
-12,61 m
-41,15 m
-4,44 m
-582,18 k
Income tax expense
-2,57 m
-17,61 m
-3,53 m
3,78 m
Effective tax rate
13,80%
17,75%
20,61%
-71,27%
Other operating expenses
-3,33 m
4,60 m
495,26 k
-2,79 m
Net income
-14,54 m
-88,79 m
-15,01 m
-8,40 m
Net profit margin
-7,13%
-45,62%
-8,24%
-5,00%
Earnings per share
-
-
-
-
Interest and investment income
6,59 m
5,60 m
5,71 m
4,89 m
Interest expense
-3,74 m
-3,38 m
-3,96 m
-1,15 m
Net interest expenses
2,86 m
2,22 m
1,76 m
3,74 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,38 m
-30,83 m
6,20 m
7,90 m
Gain or loss from assets sale
27,30 k
-34,38 k
-
-17,69 k
AI content may include mistakes. Learn more
Google-programme